Evidence map›Paper›PMID 34515521›Full record

ArticleDiabetes technology & therapeutics2022

Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study.

Satish K Garg, David Liljenquist, Bruce Bode, Mark P Christiansen, Timothy S Bailey, Ronald L Brazg, Douglas S Denham, Anna R Chang, Halis Kaan Akturk, Andrew Dehennis and 2 more

Abstract readMulticenter Study
In one paragraph

Article in Diabetes technology & therapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. A Geometrically Transient Platform for Bioelectronic Implants.Advanced materials (Deerfield Beach, Fla.) · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Proposed Recommendations for Continuous Glucose Monitor Method Comparisons.Journal of diabetes science and technology · 2024
    Article
  14. Review
  15. Article
  16. Article
  17. Patient Perspectives on the Benefits and Challenges of Diabetes and Digital Technology.Clinical diabetes : a publication of the American Diabetes Association · 2024
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Satish K GargUniversity of Colorado, Aurora, Colorado, USA.
David LiljenquistRocky Mountain Diabetes Center, Idaho Falls, Idaho, USA.
Bruce BodeAtlanta Diabetes Associates, Atlanta, Georgia, USA.
Mark P ChristiansenDiablo Clinical Research, Walnut Creek, California, USA.
Timothy S BaileyAMCR Institute, Escondido, California, USA.ORCID 0000-0003-4178-3462
Ronald L BrazgRainier Clinical Research Center, Renton, Washington, USA.
Douglas S DenhamClinical Trials of Texas, Inc., San Antonio, Texas, USA.
Anna R ChangJohn Muir Health, Concord, California, USA.
Halis Kaan AkturkUniversity of Colorado, Aurora, Colorado, USA.ORCID 0000-0003-4518-5179
Andrew DehennisSenseonics, Inc., Germantown, Maryland, USA.
Katherine S TwedenSenseonics, Inc., Germantown, Maryland, USA.ORCID 0000-0003-0942-4865
Francine R KaufmanSenseonics, Inc., Germantown, Maryland, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Blood GlucoseBlood Glucose Self-MonitoringHumansProspective StudiesReproducibility of ResultsBlood GlucoseContinuous glucose monitoringEversenseImplantable sensorPROMISE study

Identifiers

PMID34515521
PMCPMC8817689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.